Cadazolid is an investigational drug.
There have been 5 clinical trials for Cadazolid.
The most recent clinical trial was a Phase 3 trial, which was initiated on March 27th 2014.
The most common disease conditions in clinical trials are Clostridium Infections, Diarrhea, and Infection. The leading clinical trial sponsors are Actelion and [disabled in preview].
There are ten US patents protecting this investigational drug and one hundred and fifty-five international patents.